Skip to content

The Acupuncture for Pain, Opioid Use Disorder and Mood

CompletedNot applicableNCT06543355
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this study is to determine how patients with chronic pain and opioid use disorder will respond to treatment with acupuncture, including whether there will be any changes in mood (as an exploratory outcome). Results from this study have the potential to inform future studies in patients who would consider using acupuncture as an intervention for their conditions.

Study details

Official title
The Acupuncture for Pain, Opioid Use Disorder and Mood (AcuPOM) Study: A Pilot Trial
Interventions
  • Device: Modified Battlefield Acupuncture + National Acupuncture Detoxification Association protocol
Sponsor
Albert Einstein College of Medicine
Collaborators
National Institute on Drug Abuse (NIDA)
Start date
2025-01-06
Primary completion
2025-06-04
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. ≥18 years old, 2. English proficiency; 3. receiving methadone treatment at an OTP through the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability; 4. chronic pain of at least moderate pain severity (score of at least 4 on the Pain, Enjoyment of Life and General Activity (PEG) scale); 5. willingness to participate in all study components; and 6. ability to provide informed consent Exclusion Criteria: 1. Have pending surgery or invasive pain management procedure; 2. Have a pending or planned relocation; 3. have an acutely or exacerbation of psychotic, suicidal, or homicidal conditions that preclude the ability to participate; and 4. pregnancy

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06543355